fda compounding semaglutide enforcement november 2025 news September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns – Partnership for Safe Medicines Compounded "semaglutide" is not FDA-approved

Opportunities in the GLP-1 analogues market are abundant, particularly in expanding therapeutic applications, strategic collaborations, mergers, and acquisitions are reshaping the competitive landscape, while the increasing acceptance of GLP-1 therapies for chronic weight management is opening new revenue streams

In turn, that creates what some describe as an endless thirst, he says

Peptides can be administered via subcutaneous injections, nasal sprays, or oral formulations, depending on the specific treatment protocol

Gallbladder issues: Rapid weight loss can increase risk for gallstones

Exendin-4 is a high potency agonist and truncated exendin-(939)-amide an antagonist at the glucagon-like peptide 1-(736)-amide receptor of insulin-secreting -cells

In fact, some studies have even suggested the opposite